Our results provide evidence that mir-660 behaves as a tumor suppressor miRNA in lung cancer and that mir-660 replacement could represent a potential nontoxic successful therapy for a large subset of lung cancer patients where p53 locus is not genetically altered by mutation or deletion. The gene discussed is TP53; the disease is neoplasm.